Back to Search
ALIDA HANNAH, PHARM.D
PHARM.D
Pharmacist
NPI: 1346395159Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
17661(MD)
Research & Publications (20)
Food-the way to a man's heart: a mini-case series of Campylobacter perimyocarditis.
PMID 19396664·Scand J Infect Dis·2009
5-case
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.
PMID 18715642·Leuk Res·2009
8-other
Medical students' experiences of patient aggression and communication style.
PMID 19145715·Australas Psychiatry·2009
8-other
Cardiac resynchronization therapy for an unusual cause of cardiomyopathy.
PMID 17320221·Int J Cardiol·2008
5-case
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.
PMID 17618407·Invest New Drugs·2007
3-trial
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry.
PMID 17926180·Leuk Lymphoma·2007
8-other
A strategic framework for novel drug development in multiple myeloma.
PMID 17593022·Br J Haematol·2007
6-review
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.
PMID 18048823·J Clin Oncol·2007
3-trial
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.
PMID 16601426·Am J Clin Oncol·2006
3-trial
A longitudinal evaluation of medical student knowledge, skills and attitudes to alcohol and drugs.
PMID 16696628·Addiction·2006
4-observational
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
PMID 16513609·J Nucl Med·2006
3-trial
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
PMID 16000578·Clin Cancer Res·2005
3-trial
Kinases as drug discovery targets in hematologic malignancies.
PMID 16305489·Curr Mol Med·2005
6-review
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points.
PMID 16222321·Br J Cancer·2005
3-trial
Growth inhibition of foodborne and nosocomial pathogens by aqueous fraction of bearded Argostemma (Argostemma involucratum Hemsl., Rubiaceae).
PMID 16520301·J Herb Pharmacother·2005
8-other
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
PMID 15158089·Leuk Res·2004
3-trial
18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.
PMID 15596197·Urology·2004
8-other
Antimicrobial activity of Acalypha siamensis Oliv. ex Gage.
PMID 15507350·J Ethnopharmacol·2004
8-other
A communication skills course for undergraduate dental students.
PMID 15342658·J Dent Educ·2004
8-other
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.
PMID 14999430·Cancer Chemother Pharmacol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 WRAMC DEPARTMENT, 6900 GEORGIA AVENUE, NW
WASHINGTON, DC 20307 - Phone
- (202) 782-6224
Quick Facts
- NPI
- 1346395159
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile